These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9329392

  • 1. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
    Labrie F, Diamond P, Cusan L, Gomez JL, Bélanger A, Candas B.
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3498-505. PubMed ID: 9329392
    [Abstract] [Full Text] [Related]

  • 2. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 3. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women.
    Portman DJ, Labrie F, Archer DF, Bouchard C, Cusan L, Girard G, Ayotte N, Koltun W, Blouin F, Young D, Wade A, Martel C, Dubé R, other participating members of VVA Prasterone Group.
    Menopause; 2015 Dec; 22(12):1289-95. PubMed ID: 25968836
    [Abstract] [Full Text] [Related]

  • 4. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 5. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
    Labrie F, Luu-The V, Labrie C, Bélanger A, Simard J, Lin SX, Pelletier G.
    Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178
    [Abstract] [Full Text] [Related]

  • 6. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Apr; 16(5):923-31. PubMed ID: 19424093
    [Abstract] [Full Text] [Related]

  • 7. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.
    Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL, Candas B.
    Steroids; 1998 Apr; 63(5-6):322-8. PubMed ID: 9618795
    [Abstract] [Full Text] [Related]

  • 8. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
    Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4935-41. PubMed ID: 12414853
    [Abstract] [Full Text] [Related]

  • 9. Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat.
    Sourla A, Flamand M, Bélanger A, Labrie F.
    J Steroid Biochem Mol Biol; 1998 Aug; 66(3):137-49. PubMed ID: 9719448
    [Abstract] [Full Text] [Related]

  • 10. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F, Luu-The V, Labrie C, Simard J.
    Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
    [Abstract] [Full Text] [Related]

  • 11. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
    Papierska L, Rabijewski M, Kasperlik-Załuska A, Zgliczyński W.
    Adv Med Sci; 2012 Jun 01; 57(1):51-7. PubMed ID: 22430044
    [Abstract] [Full Text] [Related]

  • 12. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women.
    Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C.
    J Steroid Biochem Mol Biol; 2008 Sep 01; 111(3-5):178-94. PubMed ID: 18598765
    [Abstract] [Full Text] [Related]

  • 13. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Sep 01; 16(5):907-22. PubMed ID: 19436225
    [Abstract] [Full Text] [Related]

  • 14. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa.
    Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS.
    J Bone Miner Res; 1999 Jan 01; 14(1):136-45. PubMed ID: 9893076
    [Abstract] [Full Text] [Related]

  • 15. Is vulvovaginal atrophy due to a lack of both estrogens and androgens?
    Labrie F, Martel C, Pelletier G.
    Menopause; 2017 Apr 01; 24(4):452-461. PubMed ID: 27875388
    [Abstract] [Full Text] [Related]

  • 16. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.
    Archer DF.
    J Steroid Biochem Mol Biol; 2015 Jan 01; 145():139-43. PubMed ID: 25201455
    [Abstract] [Full Text] [Related]

  • 17. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.
    Martel C, Sourla A, Pelletier G, Labrie C, Fournier M, Picard S, Li S, Stojanovic M, Labrie F.
    J Endocrinol; 1998 Jun 01; 157(3):433-42. PubMed ID: 9691976
    [Abstract] [Full Text] [Related]

  • 18. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May 01; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 19. [Intracrinology and dehydroepiandrosterone--a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women].
    Perzyło K, Kulik-Rechberger B, Gałczyński K, Rechberger T.
    Ginekol Pol; 2011 Sep 01; 82(9):690-5. PubMed ID: 22379930
    [Abstract] [Full Text] [Related]

  • 20. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S, Panyakhamlerd K, Treratanachat S, Taechakraichana N.
    Climacteric; 2013 Feb 01; 16(1):133-40. PubMed ID: 22515801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.